Literature DB >> 19368118

MnSOD genotype and prostate cancer risk as a function of NAT genotype and smoking status.

Taro Iguchi1, Shozo Sugita, Ching Y Wang, Nancy B Newman, Tatsuya Nakatani, Gabriel P Haas.   

Abstract

BACKGROUND: Cigarette smoke contains carcinogenic aromatic and heterocyclic amines that are metabolized by N-acetyltransferase (NAT). These carcinogens also produce reactive oxygen species that are metabolized by manganese superoxide dismutase (MnSOD). The association between prostate cancer (PCA) and the polymorphism of MnSOD and NAT, and cigarette smoking was investigated. PATIENTS AND METHODS: DNA samples from 187 PCA patients and 175 age-matched controls were genotyped for MnSOD, NAT1 and NAT2 by PCR restriction fragment length polymorphism analysis and DNA sequencing.
RESULTS: MnSOD AA genotype, as compared to MnSOD VV and VA, was associated with PCA (odds ratio, 1.65; 95% confidence interval, 1.03-2.66. There was no association of PCA with NAT or smoking. Results of exploratory analyses of the data suggest that the association of PCA and MnSOD exists only in the subpopulation of rapid NAT1 genotypes and smokers.
CONCLUSION: The present study demonstrates the association of PCA and MnSOD. Oxidative stress and cigarette smoking may play an important role in the carcinogenesis of the prostate in those who have MnSOD AA and rapid NAT1 genotypes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19368118      PMCID: PMC2670457     

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  36 in total

Review 1.  Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms.

Authors:  D W Hein; M A Doll; A J Fretland; M A Leff; S J Webb; G H Xiao; U S Devanaboyina; N A Nangju; Y Feng
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2000-01       Impact factor: 4.254

2.  Association between manganese superoxide dismutase (MnSOD) gene polymorphism and breast cancer risk.

Authors:  K Mitrunen; P Sillanpää; V Kataja; M Eskelinen; V M Kosma; S Benhamou; M Uusitupa; A Hirvonen
Journal:  Carcinogenesis       Date:  2001-05       Impact factor: 4.944

Review 3.  Oxyradicals and DNA damage.

Authors:  L J Marnett
Journal:  Carcinogenesis       Date:  2000-03       Impact factor: 4.944

4.  Heterocyclic amine content of cooked meat and risk of prostate cancer.

Authors:  A E Norrish; L R Ferguson; M G Knize; J S Felton; S J Sharpe; R T Jackson
Journal:  J Natl Cancer Inst       Date:  1999-12-01       Impact factor: 13.506

5.  Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland.

Authors:  P Lichtenstein; N V Holm; P K Verkasalo; A Iliadou; J Kaprio; M Koskenvuo; E Pukkala; A Skytthe; K Hemminki
Journal:  N Engl J Med       Date:  2000-07-13       Impact factor: 91.245

6.  The Ala16Val genetic dimorphism modulates the import of human manganese superoxide dismutase into rat liver mitochondria.

Authors:  Angela Sutton; Hania Khoury; Carina Prip-Buus; Claude Cepanec; Dominique Pessayre; Françoise Degoul
Journal:  Pharmacogenetics       Date:  2003-03

Review 7.  The influence of cigarette smoking on circulating concentrations of antioxidant micronutrients.

Authors:  Anthony Alberg
Journal:  Toxicology       Date:  2002-11-15       Impact factor: 4.221

Review 8.  Inflammation and cancer.

Authors:  Lisa M Coussens; Zena Werb
Journal:  Nature       Date:  2002 Dec 19-26       Impact factor: 49.962

9.  Association of prostate cancer with rapid N-acetyltransferase 1 (NAT1*10) in combination with slow N-acetyltransferase 2 acetylator genotypes in a pilot case-control study.

Authors:  David W Hein; Matthew A Leff; Naoko Ishibe; Rashmi Sinha; Harold A Frazier; Mark A Doll; Gong H Xiao; Martin C Weinrich; Neil E Caporaso
Journal:  Environ Mol Mutagen       Date:  2002       Impact factor: 3.216

10.  Polymorphisms in oxidative stress-related genes are not associated with prostate cancer risk in heavy smokers.

Authors:  Ji-Yeob Choi; Marian L Neuhouser; Matt Barnett; Matthew Hudson; Alan R Kristal; Mark Thornquist; Irena B King; Gary E Goodman; Christine B Ambrosone
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-06       Impact factor: 4.254

View more
  16 in total

Review 1.  Manganese superoxide dismutase: beyond life and death.

Authors:  Aaron K Holley; Sanjit Kumar Dhar; Yong Xu; Daret K St Clair
Journal:  Amino Acids       Date:  2010-05-08       Impact factor: 3.520

Review 2.  Superoxide dismutase 2 gene and cancer risk: evidence from an updated meta-analysis.

Authors:  Sang Wook Kang
Journal:  Int J Clin Exp Med       Date:  2015-09-15

Review 3.  A meta-analysis of the NAT1 and NAT2 polymorphisms and prostate cancer: a huge review.

Authors:  Chunming Gong; Xueying Hu; Yong Gao; Yunfei Cao; Feng Gao; Zengnan Mo
Journal:  Med Oncol       Date:  2010-01-23       Impact factor: 3.064

Review 4.  The structural biochemistry of the superoxide dismutases.

Authors:  J J P Perry; D S Shin; E D Getzoff; J A Tainer
Journal:  Biochim Biophys Acta       Date:  2009-11-13

5.  Variation in N-acetyltransferase 2 (NAT2), smoking and risk of prostate cancer in the Slovak population.

Authors:  Marta Vilčková; Jana Jurečeková; Dušan Dobrota; Viera Habalová; Lucia Klimčáková; Iveta Waczulíková; Peter Slezák; Ján Kliment; Monika Kmeťová Sivoňová
Journal:  Med Oncol       Date:  2014-05-11       Impact factor: 3.064

6.  N-acetyltransferase-2 gene polymorphisms and prostate cancer susceptibility in Latin American patients.

Authors:  Mario Maciel de Lima Junior; Leonardo Oliveira Reis; Ana Carolina Trindade Guilhen; Fabiana Granja; Mariana Nicolau de Lima Oliveira; Ubirajara Ferreira; Lucas Leite Cunha; Laura Sterian Ward
Journal:  Med Oncol       Date:  2012-01-14       Impact factor: 3.064

7.  Increased risk of advanced prostate cancer associated with MnSOD Ala-9-Val gene polymorphism.

Authors:  Canan Kucukgergin; Oner Sanli; Tzevat Tefik; Makbule Aydın; Faruk Ozcan; Sule Seckin
Journal:  Mol Biol Rep       Date:  2011-05-08       Impact factor: 2.316

8.  MnSOD Val16Ala polymorphism and prostate cancer susceptibility: a meta-analysis involving 8,962 subjects.

Authors:  Chen Mao; Li-Xin Qiu; Ping Zhan; Kai Xue; Hong Ding; Fang-Bing Du; Jin Li; Qing Chen
Journal:  J Cancer Res Clin Oncol       Date:  2009-12-10       Impact factor: 4.553

9.  Association of NAT2 phenotype with risk of head and neck carcinoma: A meta-analysis.

Authors:  Youyang Zheng; Yong Li; Yaoshu Teng; Zhen Zhang; Xiaolin Cao
Journal:  Oncol Lett       Date:  2011-11-24       Impact factor: 2.967

10.  NAT1 polymorphisms and cancer risk: a systematic review and meta-analysis.

Authors:  Kunyi Zhang; Lijuan Gao; Yuqi Wu; Jianyi Chen; Chengguang Lin; Shaohua Liang; Jianxin Su; Jinming Ye; Xuyu He
Journal:  Int J Clin Exp Med       Date:  2015-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.